• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by Hologic Inc.

    1/16/25 4:17:28 PM ET
    $HOLX
    Medical Electronics
    Health Care
    Get the next $HOLX alert in real time by email
    DEFA14A 1 ny20038205x2_defa14a.htm DEFA14A
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    SCHEDULE 14A
    Proxy Statement Pursuant to Section 14(a) of the
    Securities Exchange Act of 1934 (Amendment No. )
    ☑
    ​ ​
    Filed by the Registrant
    ​ ​
     ☐
    ​ ​
    Filed by a Party other than the Registrant
    Check the appropriate box;
    ☐
    ​ ​
    Preliminary Proxy Statement
    ☐
    ​ ​
    Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
    ☐
    ​ ​
    Definitive Proxy Statement
    ☑
    ​ ​
    Definitive Additional Materials
    ☐
    ​ ​
    Soliciting Material Under Rule 14a-12

     
    Hologic, Inc.
    (Name of Registrant as Specified In Its Charter)
    (Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)
    Payment of Filing Fee (check all boxes that apply):
    ☑
    ​ ​
    No fee required
     ☐
    ​ ​
    Fee paid previously with preliminary materials
     ☐
    ​ ​
    Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-(6)(i) and 0-11



    Get the next $HOLX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $HOLX

    DatePrice TargetRatingAnalyst
    5/27/2025Hold
    Needham
    3/3/2025Buy → Hold
    Argus
    2/6/2025$80.00 → $75.00Outperform → Market Perform
    Leerink Partners
    2/3/2025Buy → Hold
    Needham
    12/13/2024Peer Perform
    Wolfe Research
    12/10/2024$90.00Buy
    Needham
    12/10/2024$85.00Hold
    Jefferies
    10/1/2024$95.00 → $85.00Buy → Neutral
    Citigroup
    More analyst ratings

    $HOLX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Needham reiterated coverage on Hologic

      Needham reiterated coverage of Hologic with a rating of Hold

      5/27/25 1:53:30 PM ET
      $HOLX
      Medical Electronics
      Health Care
    • Hologic downgraded by Argus

      Argus downgraded Hologic from Buy to Hold

      3/3/25 8:06:16 AM ET
      $HOLX
      Medical Electronics
      Health Care
    • Hologic downgraded by Leerink Partners with a new price target

      Leerink Partners downgraded Hologic from Outperform to Market Perform and set a new price target of $75.00 from $80.00 previously

      2/6/25 7:06:39 AM ET
      $HOLX
      Medical Electronics
      Health Care

    $HOLX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Div. President, GYN Surgical Schnittker Brandon covered exercise/tax liability with 69 shares, decreasing direct ownership by 1% to 6,094 units (SEC Form 4)

      4 - HOLOGIC INC (0000859737) (Issuer)

      6/3/25 4:19:30 PM ET
      $HOLX
      Medical Electronics
      Health Care
    • Director Madaus Martin D bought $300,760 worth of shares (5,445 units at $55.24) (SEC Form 4)

      4 - HOLOGIC INC (0000859737) (Issuer)

      5/9/25 4:39:33 PM ET
      $HOLX
      Medical Electronics
      Health Care
    • New insider Liddy Anne M. claimed ownership of 11,426 shares (SEC Form 3)

      3 - HOLOGIC INC (0000859737) (Issuer)

      5/2/25 4:52:34 PM ET
      $HOLX
      Medical Electronics
      Health Care

    $HOLX
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    See more
    • October 29, 2024 - FDA Roundup: October 29, 2024

      For Immediate Release: October 29, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA responded to objections on the agency’s final rule that removed the authorized food contact uses of most phthalates because industry abandoned these uses. The FDA evaluated the objections and concluded that they did not provide a basis for mod

      10/29/24 3:30:19 PM ET
      $HOLX
      Medical Electronics
      Health Care
    • February 2, 2024 - FDA Roundup: February 2, 2024

      For Immediate Release: February 02, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA issued a safety communication to warn consumers, health care providers, and health care facilities not to use certain Cardinal Health Monoject luer-lock and enteral syringes. Dimensional changes made to the syringes, when used with syringe pump

      2/2/24 3:58:21 PM ET
      $HOLX
      Medical Electronics
      Health Care

    $HOLX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Madaus Martin D bought $300,760 worth of shares (5,445 units at $55.24) (SEC Form 4)

      4 - HOLOGIC INC (0000859737) (Issuer)

      5/9/25 4:39:33 PM ET
      $HOLX
      Medical Electronics
      Health Care